US FDA Allows Trial of Sichuan Biokin Pharma-Bristol-Myers Squibb's Cancer Drug
US FDA Allows Trial of Sichuan Biokin Pharma-Bristol-Myers Squibb's Cancer Drug
美国食品和药物管理局允许进行四川康生制药-施贵宝公司的抗癌药物试验
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册